Jane Street Group, LLC Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $44.3 Million - $54.3 Million	189,300 New	189,300 $52.1 Million
Q1 2022 May 17, 2022	BUY	$127.18 - $173.91 $11.6 Million - $15.9 Million	91,300 Added 229.4%	131,100 $21.4 Million
Q4 2021 Feb 15, 2022	SELL	$159.56 - $209.29 $17.2 Million - $22.5 Million	-107,600 Reduced 73.0%	39,800 $6.75 Million
Q3 2021 Nov 16, 2021	BUY	$169.75 - $207.73 $3.34 Million - $4.09 Million	19,700 Added 15.43%	147,400 $27.8 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $6.52 Million - $8.97 Million	50,700 Added 65.84%	127,700 $21.6 Million
Q1 2021 May 18, 2021	BUY	$126.83 - $175.69 $1.08 Million - $1.49 Million	8,500 Added 12.41%	77,000 $10.9 Million
Q4 2020 Feb 17, 2021	SELL	$122.97 - $147.0 $209,049 - $249,900	-1,700 Reduced 2.42%	68,500 $8.9 Million
Q3 2020 Nov 17, 2020	BUY	$121.19 - $165.49 $4.79 Million - $6.54 Million	39,500 Added 128.66%	70,200 $10.2 Million
Q2 2020 Aug 17, 2020	SELL	$104.21 - $156.44 $6.39 Million - $9.59 Million	-61,300 Reduced 66.63%	30,700 $4.55 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $3.72 Million - $5.36 Million	40,000 Added 76.92%	92,000 $10 Million
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $3.68 Million - $6.14 Million	49,400 Added 1900.0%	52,000 $5.99 Million
Q1 2019 May 16, 2019	SELL	$72.76 - $93.45 $924,052 - $1.19 Million	-12,700 Reduced 83.01%	2,600 $243,000
Q4 2018 Feb 15, 2019	SELL	$62.67 - $88.33 $1.78 Million - $2.51 Million	-28,400 Reduced 64.99%	15,300 $1.12 Million
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $3.82 Million - $5.36 Million	43,700 New	43,700 $3.83 Million
Q2 2018 Aug 15, 2018	SELL	$88.31 - $107.8 $883,100 - $1.08 Million	-10,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $695,520 - $891,240	6,000 Added 150.0%	10,000 $1.19 Million
Q4 2017 Feb 15, 2018	SELL	$114.49 - $139.98 $10.6 Million - $12.9 Million	-92,500 Reduced 95.85%	4,000 $508,000
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $7 Million - $11.4 Million	96,500	96,500 $11.3 Million

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.05 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.1 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.34 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.29 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.22 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account